sensit
specif
method
analysi
anisodamin
metabolit
rat
urin
liquid
chromatographyelectrospray
ioniz
tandem
mass
spectrometri
lcmsm
develop
variou
extract
techniqu
free
fraction
acid
hydrolys
enzym
hydrolys
comparison
carri
investig
metabol
anisodamin
extract
procedur
pretreat
sampl
inject
reversedphas
column
mobil
phase
mlmin
triethylamin
solut
adjust
ph
formic
acid
vv
detect
msm
identif
structur
elucid
metabolit
perform
compar
chang
molecular
mass
retentiontim
full
scan
ms
n
spectra
parent
drug
least
metabolit
tropic
acid
ndemethylanisodamin
hydroxyanisodamin
anisodamin
noxid
hydroxyanisodamin
noxid
glucuronid
conjug
ndemethylanisodamin
sulfat
conjug
glucuronid
conjug
anisodamin
sulfat
conjug
hydroxyanisodamin
parent
drug
found
rat
urin
administr
singl
oral
dose
mgkg
anisodamin
hydroxyanisodamin
anisodamin
noxid
parent
drug
detect
rat
urin
h
ingest
anisodamin
drug
metabol
experi
play
import
role
drug
discoveri
drug
design
drug
clinic
applic
therefor
fast
effici
way
provid
accur
inform
drug
metabol
target
compound
major
metabolit
requir
past
gc
electron
captur
detect
nitrogen
phosphoru
detect
hplc
ultraviolet
uv
spectrophotometr
detect
fluoresc
detect
electrochem
detect
ecd
main
method
detect
drug
major
metabolit
vivo
technolog
provid
high
enough
sensit
specif
molecular
structur
inform
qualit
assay
drug
metabolit
coupl
gcm
technolog
overcom
insuffici
often
requir
time
consum
derivat
target
compound
method
suitabl
detect
drug
metabolit
sinc
introduct
atmospher
pressur
ioniz
api
interfac
lcm
increasingli
use
determin
drug
metabolit
preclin
clinic
studi
lcm
system
allow
analys
thermolabil
highli
polar
nonvolatil
metabolit
owe
softion
techniqu
high
sensit
target
compound
directli
determin
mixtur
without
complic
sampl
prepar
derivat
compar
lcm
lcmsm
give
us
maximum
amount
structur
inform
high
specif
qualit
analysi
trace
level
prove
power
approach
metabol
identif
drug
lcmsm
techniqu
frequent
initi
choic
metabolit
detect
identif
structur
elucid
drug
metabolit
use
lcmsm
base
premis
metabolit
retain
substructur
parent
drug
molecul
msm
product
ion
spectrum
metabolit
provid
detail
substructur
inform
structur
use
product
ion
spectrum
parent
drug
substructur
templat
metabolit
present
crude
mixtur
may
rapidli
identifi
detect
base
chang
molecular
mass
spectral
pattern
product
ion
even
without
standard
metabolit
anisodamin
tropic
ester
kind
tropan
alkaloid
extract
leav
tradit
chines
medicin
anisodu
tanguticu
synthet
form
call
widespread
activ
spasmolyt
anaesthet
acesodyn
ophthalm
effect
often
use
treat
transmiss
shock
hepat
nephriti
sugar
diabet
china
anisodamin
tent
use
treat
patient
sever
acut
respiratori
syndrom
sar
despit
import
therapeut
valu
metabol
vivo
clear
yet
till
work
focus
quantit
determin
anisodamin
rabbit
human
serum
mean
thin
layer
chromatographi
micellar
liquid
chromatographi
revers
phasehigh
perform
liquid
chromatographi
paper
highli
sensit
specif
lcmsm
method
present
identifi
anisodamin
metabolit
rat
urin
lcmsm
analys
urin
sampl
healthi
rat
administr
mgkg
anisodamin
reveal
parent
drug
eleven
metabolit
exist
rat
urin
use
futur
studi
involv
anisodamin
clinic
therapi
anisodamin
purchas
nation
institut
control
pharmaceut
biolog
product
china
escherichia
coli
purchas
sigma
st
loui
mo
usa
methanol
hplc
grade
fisher
chemic
co
inc
ca
usa
distil
water
prepar
demineralis
water
use
throughout
studi
reagent
use
analyt
grade
lcm
lcmsm
experi
perform
lcq
duo
quadrupol
ion
trap
mass
spectromet
hplc
pump
tsp
autosampl
use
posit
neg
electrospray
ioniz
process
compon
finnigan
austin
tx
usa
softwar
xcalibur
version
finnigan
appli
system
oper
data
collect
highspe
desk
centrifug
shanghai
ant
scientif
instrument
factori
china
use
centrifug
urin
sampl
urin
sampl
extract
solidphas
extract
cartridg
ml
mg
accubond
ii
agil
technolog
palo
alto
ca
usa
six
wistar
rat
obtain
hubei
experiment
anim
research
center
china
day
experi
rat
provid
standard
laboratori
food
water
ad
libitum
rat
weigh
g
time
experi
rat
hous
metabol
cage
fast
h
access
water
administ
mgkg
oral
gavag
dose
anisodamin
urin
sampl
collect
differ
timepoint
h
centrifug
g
min
supernat
store
c
analys
stock
anisodamin
solut
prepar
dissolv
anisodamin
methanol
mgml
dilut
desir
concentr
methanol
aliquot
ml
mix
h
urin
load
onto
solidphas
extract
cartridg
precondit
ml
methanol
ml
water
spe
cartridg
wash
ml
water
analyt
elut
ml
methanol
elut
solut
filter
film
aliquot
l
use
lcmsm
analys
optim
acid
heat
time
ml
hcl
mg
cystein
ad
ml
mix
h
urin
sampl
mixtur
heat
c
min
cool
room
temperatur
neutral
ph
naoh
extract
spe
cartridg
immedi
like
procedur
mention
section
optim
acid
temperatur
enzymat
content
time
hydrolysi
ml
mix
h
urin
sampl
adjust
ph
drop
glacial
acet
acid
ml
acet
buffer
ph
ml
e
coli
unitsml
ad
solut
prior
enzymat
hydrolys
took
h
c
cool
solut
adjust
ph
naoh
extract
spe
cartridg
immedi
like
procedur
mention
section
free
fraction
use
comprehens
lcmsm
analys
anisodamin
metabolit
target
solut
acid
enzymat
hydrolys
use
assist
investig
phase
ii
metabolit
reversedphas
column
aichrom
tm
reliasil
mm
mm
id
agil
technolog
palo
alto
ca
usa
connect
guard
column
cartridg
mm
mm
agil
technolog
fill
pack
materi
separ
anisodamin
metabolit
rat
urin
optim
column
temperatur
acid
mobil
phase
use
anisodamin
standard
temperatur
column
set
c
mobil
phase
consist
methanol
triethylamin
solut
adjust
ph
formic
acid
vv
elut
flow
rate
mlmin
whole
run
mass
spectral
analys
carri
use
electrospray
ioniz
esi
posit
ion
detect
mode
structur
tropic
acid
phase
ii
metabolit
valid
lcm
msm
neg
ion
detect
mode
nitrogen
use
sheath
ga
arbitrari
unit
typic
sourc
spray
voltag
kv
capillari
voltag
v
heat
capillari
temperatur
c
obtain
optim
control
condit
paramet
includ
voltag
octapol
offset
tube
len
offset
optimis
maximum
abund
ion
interest
msm
product
ion
spectra
produc
collis
induc
dissoci
cid
proton
molecular
ion
h
analyt
respect
hplc
retent
time
util
helium
ion
trap
isol
width
mz
collis
energi
ion
transit
optim
produc
highest
intens
select
ion
peak
optim
rel
collis
energi
use
ms
n
work
first
step
work
involv
character
chromatograph
mass
spectral
properti
parent
drug
chromatograph
mass
spectrometri
condit
optim
use
anisodamin
standard
full
scan
mass
spectral
analysi
anisodamin
show
proton
molecular
ion
mz
msm
product
ion
spectrum
proton
molecular
ion
mz
predomin
fragment
pattern
shown
fig
neutral
loss
key
featur
allow
identif
metabolit
lcm
chromatogram
parent
ion
mz
blank
urin
anisodamin
concentr
ngml
show
fig
fig
blank
urin
anisodamin
analyz
lcm
mode
accord
detect
mode
anisodamin
metabolit
rat
urin
fig
anisodamin
elut
min
experiment
condit
fig
specif
assay
evalu
analyz
blank
urin
sampl
rat
impur
endogen
interfer
found
fig
parent
drug
blank
urin
extract
urin
sampl
stabl
least
month
c
work
sensit
method
determin
use
anisodamin
standard
limit
detect
lod
lower
ngml
lcmsm
mean
recoveri
n
concentr
ngml
order
identifi
metabolit
possibl
structur
metabolit
specul
accord
metabol
rule
drug
firstli
full
scan
mass
spectrum
free
fraction
rat
urin
administr
anisodamin
compar
blank
urin
sampl
anisodamin
solut
find
possibl
metabolit
rat
urin
compound
analyz
lcmsm
retent
time
chang
observ
mass
spectral
pattern
product
ion
compar
anisodamin
standard
identifi
metabolit
elucid
structur
variou
extract
techniqu
free
fraction
enzym
hydrolys
acid
hydrolys
comparison
carri
investig
metabol
anisodamin
base
method
mention
parent
drug
metabolit
found
rat
urin
administra
proton
molecular
ion
mz
increas
da
compar
unchang
anisodamin
two
chromatograph
peak
appear
lcm
chromatogram
mz
retent
time
ca
min
fig
indic
hydroxyl
product
anisodamin
local
hydroxyl
group
tropic
acid
part
refer
show
rat
urin
major
metabolit
scopolamin
anoth
kind
tropan
alkaloid
three
phenol
metabolit
phydroxi
mhydroxi
phydroxymhydroxyscopolamn
product
benzyl
carbon
oxid
found
rat
urin
deduc
hydroxyanisodamin
hydroxyl
benzen
ring
appear
predomin
product
ion
mz
pair
product
ion
mz
mz
ms
spectrum
molecular
ion
fig
indic
noxid
product
parent
drug
anisodamin
noxid
cleavag
featur
noxid
loss
da
cong
theoret
expound
fragment
featur
noxid
lose
da
parent
molecul
fragment
featur
valid
use
oxymatrin
experi
characterist
product
ion
mz
appear
ms
spectrum
molecular
ion
mz
fig
increas
da
compar
parent
drug
product
ion
mz
show
part
oxid
oxid
occur
tropic
acid
part
mz
ion
show
featur
noxid
hydroxyscopolamin
noxid
fig
fragment
mz
produc
ion
mz
cleavag
n
product
ion
mz
appear
ms
spectrum
molecular
ion
mz
fig
ms
spectrum
mz
ms
spectrum
proton
molecular
ion
parent
drug
mz
product
ion
mz
produc
neutral
loss
da
diagnost
base
data
identifi
sulfat
conjug
parent
drug
deduct
valid
fact
parent
ion
mz
neg
ion
full
scan
lcm
spectrum
urin
sampl
mz
hhcho
ion
found
ms
spectrum
mz
fact
infer
hydroxyl
group
tropic
acid
conjug
sulfat
proton
molecular
ion
mz
lost
neutral
fragment
da
produc
daughter
ion
mz
fig
ms
spectrum
mz
ms
spectrum
proton
molecular
ion
mz
min
molecular
ion
mz
neg
ion
full
scan
ms
spectrum
urin
sampl
consequ
identifi
sulfat
conjug
phenol
hydroxyl
stronger
affin
higher
speed
alcohol
hydroxyl
sulfat
esterifi
reaction
accord
rule
drug
metabol
sulfat
conjug
esterifi
phenol
hydroxyl
posit
select
conjug
reaction
valid
mani
studi
ms
spectrum
mz
gave
abund
daughter
ion
mz
fig
produc
neutral
loss
da
ms
spectrum
mz
ms
spectrum
mz
besid
molecular
ion
mz
neg
ion
full
scan
lcm
spectrum
urin
sampl
gave
daughter
ion
mz
ms
spectrum
furthermor
mz
ion
appear
ms
spectrum
mz
fragment
mz
cleavag
featur
glucuronid
conjug
base
discuss
propos
major
metabol
pathway
anisodamin
rat
shown
metabolit
investig
compar
variou
extract
procedur
tabl
compar
free
fraction
peak
area
lcm
chromatogram
increas
markedli
decreas
acid
hydrolys
peak
area
increas
decreas
enzymat
hydrolysi
result
reveal
ndemethylanisodamin
unchang
anisodamin
hydroxyanisodamin
excret
rat
urin
free
sulfat
conjug
glucuronid
conjug
form
time
excret
anisodamin
metabolit
rat
urin
detect
determin
urin
sampl
collect
differ
timepoint
fig
parent
drug
eleven
metabolit
found
h
urin
parent
drug
oxid
product
could
detect
h
use
tandem
ms
techniqu
metabolit
could
detect
h
liquid
chromatographyelectrospray
ioniz
tandem
mass
spectrometri
method
develop
analysi
anisodamin
major
metabolit
rat
urin
first
time
eleven
metabolit
anisodamin
identifi
compar
chromatograph
retent
time
chang
observ
mass
tandem
ms
spectra
parent
drug
metabolit
includ
seven
phase
metabolit
tropic
acid
ndemethylanisodamin
hydroxyanisodamin
anisodamin
noxid
hydroxyanisodamin
noxid
four
phase
ii
metabolit
glucuronid
conjug
ndemethylanisodamin
sulfat
conjug
glucuronid
conjug
anisodamin
sulfat
conjug
hydroxyanisodamin
variou
extract
techniqu
comparison
valid
presenc
four
phase
ii
metabolit
parent
drug
eleven
metabolit
found
h
urin
parent
drug
predomin
metabolit
hydroxyanisodamin
anisodamin
noxid
could
detect
h
use
tandem
ms
techniqu
result
show
metabolit
specif
ms
n
fingerprint
correl
ms
n
spectrum
parent
drug
structur
metabolit
elucid
compar
ms
n
spectra
parent
drug
even
without
standard
though
structur
metabolit
determin
conclus
lcmsm
alon
present
method
still
valuabl
depend
studi
metabol
anisodamin
